Download This PaperAnti-Counterfeiting Trade Agreement (ACTA) – Implications on Developing Countries with Focus on Generic Medicines
21 Pages Posted: 7 Jul 2014
Date Written: July 5, 2014
Abstract
Anti-Counterfeiting Trade Agreement has become synonymous with controversies when it comes to intellectual property enforcement agreement. It has witnessed so many controversies of varied nature, which still continues till date. Though the idea to create a plurilateral agreement on counterfeiting was developed by Japan and the United States in 2006, the final text of ACTA was released in May 2011, it was finally on 1st October, 2011 that eight participants out of eleven involved in the rounds of negotiations signed ACTA in Tokyo.
Keywords: ACTA, Generic Medicines
Suggested Citation: Suggested Citation
Faujdar, Avijit, Anti-Counterfeiting Trade Agreement (ACTA) – Implications on Developing Countries with Focus on Generic Medicines (July 5, 2014). Available at SSRN: https://ssrn.com/abstract=2462670 or http://dx.doi.org/10.2139/ssrn.2462670
Feedback
Feedback to SSRN
If you need immediate assistance, call 877-SSRNHelp (877 777 6435) in the United States, or +1 212 448 2500 outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday.